News | September 16, 2008

Data Published From European Pilot Study of the CardioFit System for Congestive Heart Failure

September 17, 2008 - BioControl Medical said six month data for eight of the more than 30 patients who participated in the overall European pilot study of CardioFit for Congestive Heart Failure was published in the European Journal of Heart Failure, volume 10, issue 9, pages 884–891.

All eight patients were enrolled at the Fondazione IRCCS Policlinico San Matteo and the University of Pavia, Pavia, Italy. The article was authored by the study’s principal investigator, Professor Peter J. Schwartz, with his associates from Fondazione IRCCS Policlinico San Matteo and the University of Pavia, Pavia, Italy. The article is titled “Long Term Vagal Stimulation in Patients with Advanced Heart Failure: First Experience in Man.” It describes the use of CardioFit’s implantable vagal stimulation system in a pilot study designed to assess, for the first time ever, the feasibility and safety and possible efficacy of chronic vagal stimulation (VS) in congestive heart failure (CHF) patients.

“A significant 40 percent improvement was observed in the commonly used Minnesota Living with Heart Failure Quality of Life questionnaire (p

The eight patients, all with advanced CHF, had a mean age of 54 years. Two to four weeks after implantation of CardioFit, vagal stimulation was initiated and intensity increased according to a prospective protocol. “It is our opinion as investigators that the CardioFit’s novel approach to the treatment of patients with heart failure is feasible, and appears safe and tolerable. The preliminary efficacy results support the commencement of a controlled multi-center study in a larger population to confirm the seeming efficacy of the system,” Schwartz said.

The details pertaining to the six month data report on the first 20 patients in the pilot study will be addressed in a presentation at the 2008 American Heart Association annual meeting in New Orleans in November.

For more information:

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD)| July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population
News | Atrial Fibrillation| July 03, 2017
Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in...
Sponsored Content | Videos | Cardiovascular Ultrasound| June 29, 2017
Leyla Elif Sade, M.D., MESC, professor of cardiology at Başkent University, Ankara, Turkey, discusses use of echo for
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
Sponsored Content | Videos | Implantable Cardioverter Defibrillator (ICD)| June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
Overlay Init